Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial., Kuwabara Satoshi;Mori Masahiro;Misawa Sonoko;Suzuki Miki;Nishiyama Kazutoshi;Mutoh Tatsuro;Doi Shizuki;Kokubun Norito;Kamijo Mikiko;Yoshikawa Hiroo;Abe Koji;Nishida Yoshihiko;Okada Kazumasa;Sekiguchi Kenji;Sakamoto Ko;Kusunoki Susumu;Sobue Gen;Kaji Ryuji; , Journal of neurology, neurosurgery, and psychiatry, 88(10), 832-838, 2017